• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

NBS:US

5.6900 USD 0.1300 2.23%

As of 14:34:10 ET on 09/30/2014.

Snapshot for NeoStem Inc (NBS)

Open: 5.9300 Day's Range: 5.6600 - 6.0000 Volume: 81,915
Previous Close: 5.8200 52wk Range: 4.5600 - 8.9200 1-Yr Rtn: -33.57%

Stock Chart for NBS

No chart data available.
  • NBS:US 5.6920
  • 1D
  • 1M
  • 1Y
5.8200
Interactive NBS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NBS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.8100
Est. EPS (USD) (12/2014) -1.5970
Est. PEG Ratio -
Market Cap (M USD) 201.20
Shares Outstanding (M) 35.34
30 Day Average Volume 166,012
Price/Book (mrq) 2.5430
Price/Sale (ttm) 9.1234
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NBS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NBS

NeoStem, Inc. develops and manufactures cell therapies. The Company through its subsidiaries offers contract manufacturing services and is developing a cell therapy for the treatment of cardiovascular disease.

Robin L SmithChief Executive OfficerRobert Dickey IVChief Financial Officer
Andrew L PecoraChief Visionary OfficerDouglas W LosordoChief Medical Officer
More Company Profile & Key Executives for NBS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil